Isabel Ferrer
Overview
Explore the profile of Isabel Ferrer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
123
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Martinez-Romero G, Alvarino A, Hinojosa E, Mora M, Oltra L, Maroto N, et al.
Rev Esp Enferm Dig
. 2019 Apr;
111(6):431-436.
PMID: 31021170
Background: therapeutic monitoring of anti-TNF drugs and anti-drug antibody levels are useful for clinical decision-making, via the rationalization and optimization of the use of anti-TNF treatments. The objective of the...
2.
Taxonera C, Ponferrada A, Riestra S, Bermejo F, Saro C, Martin-Arranz M, et al.
J Crohns Colitis
. 2018 Jul;
12(11):1270-1279.
PMID: 30052856
Aim: To assess the likelihood of detecting latent tuberculosis infection [LTBI] by the positive conversion of a serial tuberculin skin test [TST] at 1 year in inflammatory bowel disease [IBD]...
3.
Taxonera C, Ponferrada A, Bermejo F, Riestra S, Saro C, Martin-Arranz M, et al.
J Crohns Colitis
. 2017 Mar;
11(7):792-800.
PMID: 28333182
Background And Aim: Sensitivity of tuberculin skin test [TST] during screening for latent tuberculosis infection [LTBI] is affected by steroid and/or immunosuppressant therapy. The aim of this study was to...
4.
Lozano C, Rezusta A, Ferrer I, Perez-Laguna V, Zarazaga M, Ruiz-Ripa L, et al.
Vector Borne Zoonotic Dis
. 2017 Jan;
17(4):268-270.
PMID: 28075235
Staphylococcus pseudintermedius is an opportunistic pathogen that has been identified as infectious agent or colonizer mainly in dogs. S. pseudintermedius has been also detected in humans and more specifically in...
5.
Vidal-Garcia M, Sanchez-Chueca P, Domingo M, Ballester C, Roc L, Ferrer I, et al.
Rev Iberoam Micol
. 2016 Dec;
34(1):49-52.
PMID: 27939578
Background: Disseminated invasive aspergillosis is an exceptional finding in immunocompetent hosts. As in immunocompromised patients, it has high mortality rates. Early diagnostic methods are required in order to properly manage...
6.
Alonso C, Rezusta A, Seral C, Ferrer I, Castillo F, Torres C
Enferm Infecc Microbiol Clin
. 2016 Apr;
35(9):578-581.
PMID: 27059750
Introduction: In order to study the evolution of the outbreak that occurred between 2009 and 2010 in 3 hospitals in Zaragoza, all vancomycin-resistant clinical Enterococcus faecalis isolates identified between 2011...
7.
Gonzalez-Dominguez M, Aspiroz C, Ferrer I, Toyas C
Enferm Infecc Microbiol Clin
. 2015 Sep;
34(6):395-6.
PMID: 26364858
No abstract available.
8.
Benito D, Lozano C, Rezusta A, Ferrer I, Vasquez M, Ceballos S, et al.
Int J Med Microbiol
. 2014 Dec;
304(8):1226-32.
PMID: 25444568
Unlabelled: Tetracycline-resistance (Tet(R)) has been postulated as a marker of the livestock-associated methicillin-resistant Staphylococcus aureus (MRSA) lineage CC398. Objectives Of The Study: to determine the spa-types and assigned MLST clonal...
9.
Rubin A, Sanchez-Montes C, Aguilera V, San Juan F, Ferrer I, Moya A, et al.
Transpl Int
. 2013 May;
26(7):740-50.
PMID: 23714220
There are few studies focusing on long-term complications in liver transplant (LT) recipients. The aim of this study was to define the outcome of LT recipients having survived at least...
10.
Aguilera V, Ferrer I, Berenguer M, Rivera J, Rubin A, Moya A, et al.
Ann Hepatol
. 2013 Feb;
12(2):274-81.
PMID: 23396739
Introduction: Combined liver-kidney transplantation (LKT) is the best therapeutic option for patients with end-stage liver and kidney disease. Objectives: To analyze baseline characteristics and clinical outcome of LKT compared to...